Although the regulatory mechanism of DNM1L in MASLD has not been reported, studies have suggested that DNM1L can alleviate NAS by reducing endoplasmic reticulum stress, preventing Oma1 activation, and mitigating integrated stress response deterioration [39]. This evidence concerns the gene OMA1 and neonatal abstinence syndrome.